日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylobacterium chloromethanicum 30S ribosomal protein S2 (rpsB) CSB-YP485739MSY
CSB-EP485739MSY
CSB-BP485739MSY
CSB-MP485739MSY
CSB-EP485739MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP485740MSY
CSB-EP485740MSY
CSB-BP485740MSY
CSB-MP485740MSY
CSB-EP485740MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 50S ribosomal protein L4 (rplD) CSB-YP485741MSY
CSB-EP485741MSY
CSB-BP485741MSY
CSB-MP485741MSY
CSB-EP485741MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 50S ribosomal protein L17 (rplQ) CSB-YP485742MSY
CSB-EP485742MSY
CSB-BP485742MSY
CSB-MP485742MSY
CSB-EP485742MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 50S ribosomal protein L6 (rplF) CSB-YP485743MSY
CSB-EP485743MSY
CSB-BP485743MSY
CSB-MP485743MSY
CSB-EP485743MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP485744MSY
CSB-EP485744MSY
CSB-BP485744MSY
CSB-MP485744MSY
CSB-EP485744MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Membrane protein insertase YidC (yidC), partial CSB-YP485745MSY1
CSB-EP485745MSY1
CSB-BP485745MSY1
CSB-MP485745MSY1
CSB-EP485745MSY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein matC (matC) CSB-YP485746ENM
CSB-EP485746ENM
CSB-BP485746ENM
CSB-MP485746ENM
CSB-EP485746ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli GTP cyclohydrolase-2 (ribA) CSB-YP485747ENM
CSB-EP485747ENM
CSB-BP485747ENM
CSB-MP485747ENM
CSB-EP485747ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Chaperone protein DnaJ (dnaJ) CSB-YP485748ENM
CSB-EP485748ENM
CSB-BP485748ENM
CSB-MP485748ENM
CSB-EP485748ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Carnitine operon protein CaiE (caiE) CSB-YP485749ENM
CSB-EP485749ENM
CSB-BP485749ENM
CSB-MP485749ENM
CSB-EP485749ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Glutathione-regulated potassium-efflux system ancillary protein kefF (kefF) CSB-YP485750ENM
CSB-EP485750ENM
CSB-BP485750ENM
CSB-MP485750ENM
CSB-EP485750ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli RNA polymerase-associated protein RapA (rapA), partial CSB-YP485751ENM
CSB-EP485751ENM
CSB-BP485751ENM
CSB-MP485751ENM
CSB-EP485751ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 50S ribosomal protein L5 (rplE) CSB-YP485752ENM
CSB-EP485752ENM
CSB-BP485752ENM
CSB-MP485752ENM
CSB-EP485752ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 30S ribosomal protein S19 (rpsS) CSB-YP485753ENM
CSB-EP485753ENM
CSB-BP485753ENM
CSB-MP485753ENM
CSB-EP485753ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 30S ribosomal protein S12 (rpsL) CSB-YP485754ENM
CSB-EP485754ENM
CSB-BP485754ENM
CSB-MP485754ENM
CSB-EP485754ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Protein tsgA (tsgA), partial CSB-YP485755ENM
CSB-EP485755ENM
CSB-BP485755ENM
CSB-MP485755ENM
CSB-EP485755ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Fe/S biogenesis protein NfuA (nfuA) CSB-YP485756ENM
CSB-EP485756ENM
CSB-BP485756ENM
CSB-MP485756ENM
CSB-EP485756ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 4-hydroxy-2-oxovalerate aldolase (mhpE) CSB-YP485757ENM
CSB-EP485757ENM
CSB-BP485757ENM
CSB-MP485757ENM
CSB-EP485757ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli UPF0060 membrane protein ynfA (ynfA), partial CSB-YP485758ENM1
CSB-EP485758ENM1
CSB-BP485758ENM1
CSB-MP485758ENM1
CSB-EP485758ENM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×